Rekvina Laboratories Limited (BOM:526075)
61.49
+1.60 (2.67%)
At close: Oct 16, 2026
Rekvina Laboratories Revenue
Rekvina Laboratories had revenue of 6.69M INR in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 19.34M. In the fiscal year ending March 31, 2026, Rekvina Laboratories had annual revenue of 12.65M. That makes Rekvina Laboratories the 45,461st largest company in the world by revenue and 4,895th in India.
Revenue (ttm)
19.34M
Revenue Growth
n/a
P/S Ratio
35.34
Revenue / Employee
3.87M
Employees
5
Market Cap
683.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.65M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.32B |
| ANG Lifesciences India | 835.87M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Mercury Laboratories | 737.65M |
| Shelter Pharma | 731.34M |
| Onyx Biotec | 694.69M |
| Phaarmasia | 486.17M |
| Amwill Health Care | 454.92M |